| Earnings Per Share |
8. Earnings Per Share | | | | | | | | | | | | | Three-Month Periods Ended June 30, | | Six-Month Periods Ended June 30, | | 2026 | | 2025 | | 2026 | | 2025 | Net income attributable to ordinary shareholders (numerator, in thousands) | $ | 160,720 | | $ | (38,795) | | $ | 114,407 | | $ | (78,776) | Weighted average ordinary shares outstanding – basic | | 91,418,527 | | | 80,585,625 | | | 86,387,685 | | | 79,813,273 | Dilutive effect of: | | | | | | | | | | | | Share options | | 683,185 | | | — | | | 455,049 | | | — | Restricted share units | | 1,567,148 | | | — | | | 1,210,427 | | | — | Warrants | | 136,436 | | | — | | | 61,862 | | | — | Weighted average ordinary shares outstanding – diluted | | 93,805,296 | | | 80,585,625 | | | 88,115,023 | | | 79,813,273 | Basic earnings per ordinary share | $ | 1.76 | | $ | (0.48) | | $ | 1.32 | | $ | (0.99) | Diluted earnings per ordinary share | $ | 1.71 | | $ | (0.48) | | $ | 1.30 | | $ | (0.99) |
The following securities are considered to be ordinary share equivalents, but were not included in the computation of diluted net loss per ordinary share for the six-month periods ended June 30, 2026 and 2025 because their effect was anti-dilutive: | | | | | | | June 30, | | June 30, | | | 2026 | | 2025 | Share options | | 4,718,960 | | 8,060,305 | Restricted share units | | — | | 6,252,250 | Warrants | | — | | 700,000 | | | 4,718,960 | | 15,012,555 |
|